Literature DB >> 59511

The spontaneous regression of keratoacanthoma in man.

C G Ramselaar, J B van der Meer.   

Abstract

This study was undertaken to search for immune mediated mechanisms which could possibly be involved in the spontaneous regression of keratoacanthomas. In eleven patients with solitary keratoacanthoma, immunofluorescence studies did not reveal significant staining patterns, while skin tests, using autologous extracts of keratoacanthomas, were not compatible with true delayed cutaneous hypersensitivity reactions.

Entities:  

Mesh：

Year:  1976        PMID： 59511

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN： 0001-5555            Impact factor:   4.437


  7 in total

1.  Keratoacanthoma.

Authors:  Walter Espinoza; Covadonga Perez; Pedro Cuevas
Journal:  BMJ Case Rep       Date:  2009-04-28

2.  Hypocomplementemia in keratoacanthoma.

Authors:  J M Bonnetblanc; N Gualde; F Bonnetblanc
Journal:  Arch Dermatol Res       Date:  1981       Impact factor: 3.017

3.  Oncogene activation in human benign tumors of the skin (keratoacanthomas): is HRAS involved in differentiation as well as proliferation?

Authors:  M Corominas; H Kamino; J Leon; A Pellicer
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

4.  Immunological study of keratoacanthomas.

Authors:  A Tosca; A Varelzidis; G Avgerinou; J Hatzis; A Perissios; G Nicolis
Journal:  Arch Dermatol Res       Date:  1980       Impact factor: 3.017

5.  H-ras activation in benign and self-regressing skin tumors (keratoacanthomas) in both humans and an animal model system.

Authors:  J Leon; H Kamino; J J Steinberg; A Pellicer
Journal:  Mol Cell Biol       Date:  1988-02       Impact factor: 4.272

Review 6.  ras activation in human tumors and in animal model systems.

Authors:  M Corominas; S R Sloan; J Leon; H Kamino; E W Newcomb; A Pellicer
Journal:  Environ Health Perspect       Date:  1991-06       Impact factor: 9.031

7.  Loss of heterozygosity analysis of keratoacanthoma reveals multiple differences from cutaneous squamous cell carcinoma.

Authors:  A J Waring; M Takata; I Rehman; J L Rees
Journal:  Br J Cancer       Date:  1996-03       Impact factor: 7.640
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.